BioSpyder Expands Presence in South Korea Through Distribution Partnership with LAS

BioSpyder Technologies, Inc. is pleased to announce its continued expansion into the South Korean market through its distribution partnership with LAS, a South Korean life science supplier supporting researchers across biomedical, pharmaceutical, and laboratory research communities. 

This partnership represents an important step in making BioSpyder’s TempO-Seq™ platform more accessible to researchers and organizations throughout South Korea. As demand continues to grow scalable, cost-effective, and high-throughput gene expression profiling technologies, BioSpyder is focused on building trusted regional partnerships that can provide local access, technical support, and market expertise. 

TempO-Seq enables high-throughput targeted gene expression profiling with simplified workflows, scalable sample processing, and broad applicability across toxicology, drug discovery, environmental health, oncology, translational research, and other areas of biomedical science. By working with LAS in South Korea, BioSpyder aims to support local researchers seeking practical alternatives to traditional RNA sequencing for large sample studies, screening applications, and targeted molecular profiling. 

The partnership is part of BioSpyder’s broader commercial strategy to expand its global distribution network and strengthen access to TempO-Seq in key international research markets. South Korea represents an important life science and biotechnology market, with strong activity across pharmaceutical research, toxicology, genomics, precision medicine, and translational science. 

“South Korea is a highly innovative life science market, and we are excited to work with LAS to support researchers in the region,” said Garrett McComb, Director of BioSpyder Technologies. “This partnership helps expand access to TempO-Seq for organizations seeking scalable, cost-effective gene expression profiling across various industries in the country”. 

For more information about TempO-Seq and BioSpyder’s innovative technologies, please visit BioSpyder’s at www.biospyder.com.